相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Development of vorinostat: Current applications and future perspectives for cancer therapy
Victoria M. Richon et al.
CANCER LETTERS (2009)
Microtubule dynamics as a target in oncology
April L. Risinger et al.
CANCER TREATMENT REVIEWS (2009)
How do anti-mitotic drugs kill cancer cells?
Karen E. Gascoigne et al.
JOURNAL OF CELL SCIENCE (2009)
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
Edith A. Perez
MOLECULAR CANCER THERAPEUTICS (2009)
Histone deacetylase 3 is required for centromeric H3K4 deacetylation and sister chromatid cohesion
Gregory Eot-Houllier et al.
GENES & DEVELOPMENT (2008)
Vincristine and lomustine induce apoptosis and p21WAF1 up-regulation in medulloblastoma and normal human epithelial and fibroblast cells
Zakia Shinwari et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
C. Boyault et al.
ONCOGENE (2007)
Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint
Laura Magnaghi-Jaulin et al.
CANCER RESEARCH (2007)
Histone deacetylase inhibitors in cancer therapy
Walid K. Rasheed et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo
Quang T. Luong et al.
CLINICAL CANCER RESEARCH (2006)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Understanding microtubule dynamics for improved cancer therapy
S Honore et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Rational development of histone deacetylase inhibitors as anticancer agents: A review
MR Acharya et al.
MOLECULAR PHARMACOLOGY (2005)
Mitotic spindle checkpoint inactivation by trichostatin A defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents
M Dowling et al.
CANCER BIOLOGY & THERAPY (2005)
Review: Tubulin function, action of antitubulin drugs, and new drug development
F Pellegrini et al.
CANCER INVESTIGATION (2005)
Upregulation and nuclear recruitment of HDACI in hormone refractory prostate cancer
K Halkidou et al.
PROSTATE (2004)
Cell death by mitotic catastrophe: a molecular definition
M Castedo et al.
ONCOGENE (2004)
Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation
SJ Nowak et al.
TRENDS IN GENETICS (2004)
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
P Zhu et al.
CANCER CELL (2004)
Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition
EJ Noh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Class II histone deacetylases: versatile regulators
E Verdin et al.
TRENDS IN GENETICS (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Y Zhang et al.
EMBO JOURNAL (2003)
In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation
A Matsuyama et al.
EMBO JOURNAL (2002)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Duration of nuclear NF-κB action regulated by reversible acetylation
LF Chen et al.
SCIENCE (2001)
Deacetylation of p53 modulates its effect on cell growth and apoptosis
JY Luo et al.
NATURE (2000)
Regulation of E2F1 activity by acetylation
MA Martínez-Balbás et al.
EMBO JOURNAL (2000)
P21-dependent G(1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
V Sandor et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
